CLPHY(CLPHY)
CLPHY
No analyst ratings available
No analyst price targets available for CLPHY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $88.51B | $90.20B | $91.62B |
| Low | $83.55B | $83.00B | $85.39B |
| High | $94.73B | $97.20B | $98.40B |
| EBITDA Avg | $29.83B | $30.40B | $30.88B |
| Low | $28.16B | $27.98B | $28.78B |
| High | $31.93B | $32.76B | $33.17B |
| EBIT Avg | $19.78B | $20.16B | $20.48B |
| Low | $18.67B | $18.55B | $19.09B |
| High | $21.17B | $21.72B | $21.99B |
| Net Income Avg | $12.35B | $12.69B | $13.54B |
| Low | $11.26B | $11.57B | $12.34B |
| High | $13.54B | $13.91B | $14.84B |
| EPS Avg | $4.89 | $5.02 | $5.36 |
| Low | $4.46 | $4.58 | $4.88 |
| High | $5.36 | $5.51 | $5.87 |
| Analysts (Rev / EPS) | 8 / 1 | 8 / 1 | 6 / 1 |